Zhao, Yong <br/><br/>
Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial.  [electronic resource] 

 -  BMC medicine  Jul 2013 
 - 160 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1741-7015 
<br/><br/><label>Standard No.: </label>10.1186/1741-7015-11-160  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Coculture Techniques<br/>Diabetes Mellitus, Type 2--immunology<br/>Female<br/>Fetal Blood--immunology<br/>Follow-Up Studies<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Immunomodulation--drug effects<br/>Insulin Resistance--immunology<br/>Male<br/>Middle Aged<br/>Molecular Targeted Therapy--methods<br/>Multipotent Stem Cells--immunology<br/>Stem Cell Transplantation--methods<br/>Transplantation, Autologous